SubstantialExitHistoryLeroyHood,M.D.,Ph.D.Turn-KeyFacilitiesTachiYamada,M.D.DanaFarberCancerStrategicPartnershipsTheRockefellerUniversityDivestituresSyndication$12.3MillionNIDAGrantMDAndersonCancerCenterScientists&TechnologyDevelopers$3.375BillionExitApogenBiotechnologies1.02DPIRodeoTherapeuticsSanDiegoOfficeAbbvieSteveGillis,Ph.D.EmployeesEntrepreneursAdvisory&CorporateBoardsWeillCornellMedicineUniformedServicesUniversityCSABMembers?WRFCapitalhigh-quality,cutting edgelife sciencecompaniesNon-DilutiveFundingSyndicationPartnersHarvardMedicalSchoolTop-tierInvestorsJanLundberg,Ph.D.CPRIT2.85DVPIRodeoTherapeutics$1 BillionGenentechCollaboration(BARDA)– onupdatedslide deckDiversityBruceL.A.Carter,Ph.D.TargetedTherapeutic(Asset)FinancingNewYorkOfficeAI &MachineLearningLydianNeurosciencesFund Inet IRRof 58.4%ExceptionalTrackRecordSundarKodiyalam2014 Top-quartileRankedCapital-efficiencyNeuroscience& NeurologyAlexandriaVentureInvestmentsSingaporeOfficeTemasekColumbiaUniversityTheRockefellerUniversitySeattleOfficePennStateGatesFoundation150+Years’ExperienceWuXiPharmaTechWeillCornellMedicineCorporateSpinouts58.43%IRRReviewed >4,000OpportunitiesGatesFoundationPetraPharmaScientificExpertiseUniversityofMinnesotaUTSouthwesternMedicalCenterOncologyInfectiousDisease,Oncology,MicrobiomeAcademic&ResearchInstitutionsLodoTherapeuticsVentureCapitalEliLillyGeneYeo,Ph.D.PronirasMagnoliaNeurosciencesLodoTherapeuticsUTSouthwesternOperatingPartners?CaseWesternReservePfizerVenturesARCHVenturePartnersLewisCantleySubstantialExitHistoryLeroyHood,M.D.,Ph.D.Turn-KeyFacilitiesTachiYamada,M.D.DanaFarberCancerStrategicPartnershipsTheRockefellerUniversityDivestituresSyndication$12.3MillionNIDAGrantMDAndersonCancerCenterScientists&TechnologyDevelopers$3.375BillionExitApogenBiotechnologies1.02DPIRodeoTherapeuticsSanDiegoOfficeAbbvieSteveGillis,Ph.D.EmployeesEntrepreneursAdvisory&CorporateBoardsWeillCornellMedicineUniformedServicesUniversityCSABMembers?WRFCapitalhigh-quality,cutting edgelife sciencecompaniesNon-DilutiveFundingSyndicationPartnersHarvardMedicalSchoolTop-tierInvestorsJanLundberg,Ph.D.CPRIT2.85DVPIRodeoTherapeutics$1 BillionGenentechCollaboration(BARDA)– onupdatedslide deckDiversityBruceL.A.Carter,Ph.D.TargetedTherapeutic(Asset)FinancingNewYorkOfficeAI &MachineLearningLydianNeurosciencesFund Inet IRRof 58.4%ExceptionalTrackRecordSundarKodiyalam2014 Top-quartileRankedCapital-efficiencyNeuroscience& NeurologyAlexandriaVentureInvestmentsSingaporeOfficeTemasekColumbiaUniversityTheRockefellerUniversitySeattleOfficePennStateGatesFoundation150+Years’ExperienceWuXiPharmaTechWeillCornellMedicineCorporateSpinouts58.43%IRRReviewed >4,000OpportunitiesGatesFoundationPetraPharmaScientificExpertiseUniversityofMinnesotaUTSouthwesternMedicalCenterOncologyInfectiousDisease,Oncology,MicrobiomeAcademic&ResearchInstitutionsLodoTherapeuticsVentureCapitalEliLillyGeneYeo,Ph.D.PronirasMagnoliaNeurosciencesLodoTherapeuticsUTSouthwesternOperatingPartners?CaseWesternReservePfizerVenturesARCHVenturePartnersLewisCantley

Home for the Holidays (& everyday) - Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
  1. Substantial Exit History
  2. Leroy Hood, M.D., Ph.D.
  3. Turn-Key Facilities
  4. Tachi Yamada, M.D.
  5. Dana Farber Cancer
  6. Strategic Partnerships
  7. The Rockefeller University
  8. Divestitures
  9. Syndication
  10. $12.3 Million NIDA Grant
  11. MD Anderson Cancer Center
  12. Scientists & Technology Developers
  13. $3.375 Billion Exit
  14. Apogen Biotechnologies
  15. 1.02 DPI
  16. Rodeo Therapeutics
  17. San Diego Office
  18. Abbvie
  19. Steve Gillis, Ph.D.
  20. Employees
  21. Entrepreneurs
  22. Advisory & Corporate Boards
  23. Weill Cornell Medicine
  24. Uniformed Services University
  25. CSAB Members?
  26. WRF Capital
  27. high-quality, cutting edge life science companies
  28. Non-Dilutive Funding
  29. Syndication Partners
  30. Harvard Medical School
  31. Top-tier Investors
  32. Jan Lundberg, Ph.D.
  33. CPRIT
  34. 2.85 DVPI
  35. Rodeo Therapeutics
  36. $1 Billion Genentech Collaboration
  37. (BARDA) – on updated slide deck
  38. Diversity
  39. Bruce L.A. Carter, Ph.D.
  40. Targeted Therapeutic (Asset) Financing
  41. New York Office
  42. AI & Machine Learning
  43. Lydian Neurosciences
  44. Fund I net IRR of 58.4%
  45. Exceptional Track Record
  46. Sundar Kodiyalam
  47. 2014 Top-quartile Ranked
  48. Capital-efficiency
  49. Neuroscience & Neurology
  50. Alexandria Venture Investments
  51. Singapore Office
  52. Temasek
  53. Columbia University
  54. The Rockefeller University
  55. Seattle Office
  56. Penn State
  57. Gates Foundation
  58. 150+ Years’ Experience
  59. WuXi PharmaTech
  60. Weill Cornell Medicine
  61. Corporate Spinouts
  62. 58.43% IRR
  63. Reviewed > 4,000 Opportunities
  64. Gates Foundation
  65. Petra Pharma
  66. Scientific Expertise
  67. University of Minnesota
  68. UT Southwestern Medical Center
  69. Oncology
  70. Infectious Disease, Oncology, Microbiome
  71. Academic & Research Institutions
  72. Lodo Therapeutics
  73. Venture Capital
  74. Eli Lilly
  75. Gene Yeo, Ph.D.
  76. Proniras
  77. Magnolia Neurosciences
  78. Lodo Therapeutics
  79. UT Southwestern
  80. Operating Partners?
  81. Case Western Reserve
  82. Pfizer Ventures
  83. ARCH Venture Partners
  84. Lewis Cantley